Nexalin Technology (NXL) Liabilities and Shareholders Equity (2021 - 2026)

Nexalin Technology (NXL) recorded quarterly Liabilities and Shareholders Equity of $3.7 million in Q1 2026, down 20.29% quarter-over-quarter from $4.6 million in Q4 2025, and up 27.4% on a YoY basis from $2.9 million in Q1 2025.

Nexalin Technology (NXL) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Nexalin Technology's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $3.7 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 27.4% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $20.0 million (up 43.58% YoY), while the FY2025 annual figure was $4.6 million, up 9.77% from the prior year.
  • Liabilities and Shareholders Equity was $3.7 million for Q1 2026 at Nexalin Technology, down from $4.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $8.4 million in Q3 2022 to a low of $1.6 million in Q2 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $4.8 million across 5 years, with a median of $4.6 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 886.09% in 2022, then plunged 69.8% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $7.4 million in 2022, then slumped by 51.13% to $3.6 million in 2023, then advanced by 16.27% to $4.2 million in 2024, then gained by 9.77% to $4.6 million in 2025, then retreated by 20.29% to $3.7 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $3.7 million (Q1 2026), $4.6 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Nexalin Technology 7.82 Mn 5.11 Mn 13,133.00 3.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.69 Mn
Dec 31, 2025 4.64 Mn
Sep 30, 2025 5.13 Mn
Jun 30, 2025 6.56 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 4.22 Mn
Sep 30, 2024 5.26 Mn
Jun 30, 2024 1.56 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 3.63 Mn
Sep 30, 2023 4.43 Mn
Jun 30, 2023 5.18 Mn
Mar 31, 2023 5.93 Mn
Dec 31, 2022 7.43 Mn
Sep 30, 2022 8.35 Mn
Dec 31, 2021 753,698.00